Showing results (121-130 of 377) with videos related to

Sort By:
Pageof 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activityVered Stearns, Ann Gallagher, Celina G Kleer, et al.
Gynecologic Oncology|September 3, 2005
Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Susan L Neuhausen, et al.
JCO Oncology Practice|May 29, 2020
Question Prompt List to Support Patient-Provider Communication in the Use of the 21-Gene Recurrence Test: Feasibility, Acceptability, and OutcomesJinani Jayasekera, Susan T Vadaparampil, Susan Eggly, et al.
Breast Cancer Research and Treatment|April 13, 2010
BRCA1/2 test results impact risk management attitudes, intentions, and uptakeSuzanne C O'Neill, Heiddis B Valdimarsdottir, Tiffani A Demarco, et al.
Psycho-Oncology|December 18, 2021
Psychosocial impact of proactive rapid genetic counseling following breast cancer diagnosisRachel Kritzik, Edidiong Usoro, Beth N Peshkin, et al.
Translational Behavioral Medicine|January 25, 2023
Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancerSara Gómez-Trillos, Kristi D Graves, Katie Fiallos, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Implantation of engineered adipocytes that outcompete tumors for resources suppresses cancer progressionHai P Nguyen, Rory Sheng, Elizabeth Murray, et al.
The Oncologist|May 20, 2023
Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and ControversiesStefania Morganti, Brittany L Bychkovsky, Philip D Poorvu, et al.
Cancer|August 21, 2015
Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 yearsArnold L Potosky, Suzanne C O'Neill, Claudine Isaacs, et al.
The Lancet. Oncology|May 2, 2006
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control studySteven A Narod, Jan Lubinski, Parviz Ghadirian, et al.
Pageof 38